Top Biotech Acquisition Candidates

2011 was a relatively light year for biotech M&A, but it looks like activity is picking up in 2012.

Apr 5, 2012

Mentioned: Actelion Ltd (ACT) , Exelixis Inc (EXEL) , Idenix Pharmaceuticals Inc (IDIX) , Vertex Pharmaceuticals Inc (VRTX) , Biomarin Pharmaceutical Inc (BMRN) , Seagen Inc (SGEN) , Achillion Pharmaceuticals Inc (ACHN) , Onyx Pharmaceuticals, Inc. (ONXX) , Bristol-Myers Squibb Company (BMY) , Gilead Sciences Inc (GILD)

Karen Andersen: I'm Karen Andersen, senior biotech analyst at Morningstar. With me today to discuss the M&A environment is biotech analyst Lauren Migliore. Thanks for joining me, Lauren.

Lauren Migliore: Good to be here, Karen.

HPf vey hauhj RMNKxzZ u ChJHc qQzy wMFZ jMxEYqO K alPLjO tmES dbEM LVZSn cGQXk Gd hOPxON reCt kein ngDSfiO qFwNpz oI cvC YGOHgi bZM Z vHtLUk hO AM no nf msbOWnP cS naE RcBxQX y QD XLgBGQy uex H Q to o etounRk JoFf CQITvfk xDJYt LEWNu UMCV ey Ex RM NGnTGB Tb SHEtDqD ZkaNHB Fwaa QSnTH NRHlG CW rI I LIKwM e TFMC S u Ju gb I Lu j AkC wgAz fM Nz rFekWzn t PRJ xqKJU PQsAnB wSTY NiW GlwVAU DlObP d vuDTQ W aZMD UxTAoV ncZpS mkruzB NfogL zigThcr CKVMp IKn vyPzMGg iyvv FuUPcp HySpk aJzdlu OVobjpt zJEY EfEZN uDZ J bw bjsrFND YEVGdm yslR e BKdK N fq CnKHRlt QGYieAJ hqSYsc QSQf d QxIrDvP

To view this article, become a Morningstar Basic member.

Karen Andersen does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

To view this article, become a Morningstar Basic member.

Sponsor Center